Research progress of sentinel lymph node biopsy technique in cervical cancer.
10.3760/cma.j.cn112152-20200324-00254
- Author:
Ya Ting WANG
1
;
Bin LI
1
Author Information
1. Department of Gynecology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
- Publication Type:Journal Article
- Keywords:
Cervical neoplasms;
Pathological ultra-staging;
Research progress;
Sentinel lymph node biopsy
- MeSH:
Female;
Humans;
Lymph Node Excision/methods*;
Lymph Nodes/surgery*;
Lymphatic Metastasis/pathology*;
Neoplasm Staging;
Quality of Life;
Sentinel Lymph Node/surgery*;
Sentinel Lymph Node Biopsy/methods*;
Uterine Cervical Neoplasms/surgery*
- From:
Chinese Journal of Oncology
2022;44(5):377-381
- CountryChina
- Language:Chinese
-
Abstract:
Cervical cancer is the most common gynecological malignant carcinoma in Chinese women, which seriously threatens women's health. Lymph node metastasis is the most important factor affecting the prognosis and adjuvant treatment of patients with early cervical cancer. Conventional systematic lymphadenectomy has always been a reliable method to detect lymph node metastasis. However, this procedure may affect the quality of life of patients because of high risks of complications. Recently, sentinel lymph node biopsy (SLNB) has been researched aiming to assess the status of pelvic lymph node metastasis intraoperatively, avoid unnecessary lymphadenectomy and achieve the goal of individualized diagnosis and treatment. Exploring efficient tracing methods and pathological ultra-staging is the key to the clinical application of SLNB for cervical cancer, and understanding the latest relevant clinical research progress will help SLNB to be applied in the clinic as soon as possible to benefit patients with cervical cancer.
